Name : Kitov Pharma Ltd
Current / Former Name: Purple Biotech Ltd. (Successor)
Address: 4 Oppenheimer Street, Science Park, Rehovot 7670104, Israel
Phone Number: +972 3-933-3121
Investor Relations Contact: ir@purple-biotech.com
Website - https://purple-biotech.com
Warrant Details
Warrant Symbol: PPBT (NASDAQ) / Former: KTOV (NASDAQ)
Warrants Listed: 4,140,000
Ratio: 1-for-1
Cusip Number: 49806A 13 9
ISIN Number: US49806A1394
Parent Stock Symbol: KAII (NASDAQ)
Underlying Stock Cusip: 74638P 10 9
Expiry Date - November 25, 2020
Exercise Price: $4.13 USD
Synopsis & Listing Information
Kitov Pharma Ltd. was a clinical-stage pharmaceutical development enterprise specialized in oncology therapeutics designed to overcome tumor immune evasion and drug resistance.
Listing History: The company's American Depositary Shares (ADSs) and bundled warrants were formally introduced to the US public markets via the Nasdaq. The warrants traded under the independent ticker symbol KTOVW.
Corporate Rebranding & Expiration: The enterprise implemented a comprehensive corporate transformation, changing its name from Kitov Pharma Ltd. to Purple Biotech Ltd. while shifting its primary ticker symbol to PPBT.
Current Status: The historical public KTOVW warrants reached their final hard contract maturity date on November 25, 2020. They ceased public quotes, were completely unlisted, and expired out-of-the-money.
Current / Former Name: Purple Biotech Ltd. (Successor)
Address: 4 Oppenheimer Street, Science Park, Rehovot 7670104, Israel
Phone Number: +972 3-933-3121
Investor Relations Contact: ir@purple-biotech.com
Website - https://purple-biotech.com
Warrant Details
Warrant Symbol: PPBT (NASDAQ) / Former: KTOV (NASDAQ)
Warrants Listed: 4,140,000
Ratio: 1-for-1
Cusip Number: 49806A 13 9
ISIN Number: US49806A1394
Parent Stock Symbol: KAII (NASDAQ)
Underlying Stock Cusip: 74638P 10 9
Expiry Date - November 25, 2020
Exercise Price: $4.13 USD
Synopsis & Listing Information
Kitov Pharma Ltd. was a clinical-stage pharmaceutical development enterprise specialized in oncology therapeutics designed to overcome tumor immune evasion and drug resistance.
Listing History: The company's American Depositary Shares (ADSs) and bundled warrants were formally introduced to the US public markets via the Nasdaq. The warrants traded under the independent ticker symbol KTOVW.
Corporate Rebranding & Expiration: The enterprise implemented a comprehensive corporate transformation, changing its name from Kitov Pharma Ltd. to Purple Biotech Ltd. while shifting its primary ticker symbol to PPBT.
Current Status: The historical public KTOVW warrants reached their final hard contract maturity date on November 25, 2020. They ceased public quotes, were completely unlisted, and expired out-of-the-money.
American Financial News
Loading the latest American market news...
American Financial News
Loading the latest American market news...